1. Home
  2. GRNQ vs ABP Comparison

GRNQ vs ABP Comparison

Compare GRNQ & ABP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRNQ
  • ABP
  • Stock Information
  • Founded
  • GRNQ 2013
  • ABP 2004
  • Country
  • GRNQ Malaysia
  • ABP United States
  • Employees
  • GRNQ N/A
  • ABP N/A
  • Industry
  • GRNQ EDP Services
  • ABP Biotechnology: Pharmaceutical Preparations
  • Sector
  • GRNQ Technology
  • ABP Health Care
  • Exchange
  • GRNQ Nasdaq
  • ABP Nasdaq
  • Market Cap
  • GRNQ 13.3M
  • ABP 15.5M
  • IPO Year
  • GRNQ 2018
  • ABP N/A
  • Fundamental
  • Price
  • GRNQ $1.54
  • ABP $0.21
  • Analyst Decision
  • GRNQ
  • ABP Strong Buy
  • Analyst Count
  • GRNQ 0
  • ABP 1
  • Target Price
  • GRNQ N/A
  • ABP $4.00
  • AVG Volume (30 Days)
  • GRNQ 85.5K
  • ABP 5.6M
  • Earning Date
  • GRNQ 08-12-2025
  • ABP 08-18-2025
  • Dividend Yield
  • GRNQ N/A
  • ABP N/A
  • EPS Growth
  • GRNQ N/A
  • ABP N/A
  • EPS
  • GRNQ N/A
  • ABP N/A
  • Revenue
  • GRNQ $3,190,761.00
  • ABP $183,000.00
  • Revenue This Year
  • GRNQ N/A
  • ABP N/A
  • Revenue Next Year
  • GRNQ N/A
  • ABP N/A
  • P/E Ratio
  • GRNQ N/A
  • ABP N/A
  • Revenue Growth
  • GRNQ N/A
  • ABP 88.66
  • 52 Week Low
  • GRNQ $0.80
  • ABP $0.15
  • 52 Week High
  • GRNQ $2.24
  • ABP $11.19
  • Technical
  • Relative Strength Index (RSI)
  • GRNQ 56.94
  • ABP N/A
  • Support Level
  • GRNQ $1.47
  • ABP N/A
  • Resistance Level
  • GRNQ $1.70
  • ABP N/A
  • Average True Range (ATR)
  • GRNQ 0.18
  • ABP 0.00
  • MACD
  • GRNQ -0.01
  • ABP 0.00
  • Stochastic Oscillator
  • GRNQ 48.19
  • ABP 0.00

About GRNQ Greenpro Capital Corp.

Greenpro Capital Corp operates and provides business solution services to small and medium-sized businesses located in Southeast Asia and East Asia, with a focus on Hong Kong, China and Malaysia, and in Thailand and Taiwan. Its range of services includes cross-border business solutions, record management services, and accounting outsourcing services. Cross-border business services include other services, tax planning, trust and wealth management. Its segments include Service business engaged in the provision of corporate advisory and business solution services; Real estate business segment engaged in trading or leasing of commercial real estate properties in Hong Kong and Malaysia; and Digital business segment engaged in provision of digital platform and trading of digital assets.

About ABP Abpro Holdings Inc Common Stock

Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.

Share on Social Networks: